| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q4 | Feb 8, 2026 | SGA – International Growth | 1.0% | 9.6% | 1299.HK, 6098.T, 9983.T, ADYEN.AS, ALC, AON, ARM, BABA, CP, DSY.PA, EXPN.L, FEMSAUBD.MX, GALD, GRAB, HDFCBANK.NS, HEIA.AS, HLN.L, INFY, LIN, MELI, OR.PA, SAP, SE, SGE.L, SHOP, SRT3.DE, STE, TEAM, TSM, UL, UMG.AS, WALMEX.MX, WCN, YUMC | AI, Cyclical, E-Commerce, growth, international, Quality, Southeast Asia, valuation | SGA continues to believe the most attractive long-term AI opportunities reside with businesses building long-term value through proprietary data and integrated workflows. The portfolio is positioned to capture AI value through companies providing essential intellectual property and manufacturing capability for the AI ecosystem, including TSMC, Arm Holdings, SAP, and Dassault Systemes. The portfolio focuses on high-conviction quality growth businesses anticipated to achieve consistent mid-teens earnings growth with reduced variability. Despite market headwinds favoring cyclical assets, SGA maintains conviction in quality companies with predictable revenue and cash flow generation that should become more sought after if market volatility increases. New positions were established in Sea Limited and Grab Holdings, both Southeast Asian consumer internet companies with integrated ecosystems. Sea operates Shopee e-commerce platform with integrated payments and logistics, while Grab provides super-app services for ride-hailing, food delivery, and digital payments across Southeast Asia. | TEAM ARM DSY FP SRT GR 9983 JP |
View |
| 2024 Q4 | Dec 31, 2024 | Artisan Global Discovery | 2.7% | 16.1% | ARGX, ASND, FWONA, GALDF, GXI.DE, HUBS, INSM, LYV, MPWR, MTSI, NZYM-B.CO, ON, ONTO, PSTG, SE, SGE.L, SPOT, SRT3.DE, TEAM, VCYT, WST | AI, Biotechnology, global, growth, healthcare, semiconductors, technology | Data centers are energy-intensive and with AI expansion, energy consumption is projected to grow exponentially. The team owns multiple technology category leaders positioned to help enable AI advances, including MACOM for networking chips, PureStorage for data storage, and Onto Innovation for inspection systems. Cloud software franchises are making steady progress introducing AI functionality into their leading solution suites. | View | |
| 2023 Q4 | Sep 3, 2024 | Concentrated Compounding | 0.0% | 0.0% | AMZN, BRK-B, CHTR, CRM, CSU.TO, DHR, EPD, GOOGL, MA, MSFT, SPGI, SRT3.DE, TDG, TMO, V | Concentration, long-term, Quality, risk management, Treasuries, Valuations | Manager extensively discusses how stock valuations have moved from undervalued to fair value throughout 2023, leading to position trimming. Current market valuations are described as high relative to historical levels, with P/E ratios at 20-year highs excluding 2021. | SRT3.DE ADI|BDX|FI|FND|HAS|META|MSFT|MSI|ORCL|TMO DHR |
View |
| 2024 Q2 | Jun 30, 2024 | Mar Vista Global Equity Fund | 7.2% | - | AAPL, ADBE, AMZN, AVGO, CRM, DIS, GOOGL, LIN, META, MSFT, NVDA, NVS, ORCL, SRT3.DE | AI, Cloud, global, growth, large cap, semiconductors, technology | AI enthusiasm has driven approximately 49% of global market gains year-to-date, with six megacap firms leading the rally. The manager believes AI will have transformative long-term effects but notes the market is pricing in immediacy while benefits will accrue gradually. AI advancements are already showing promising results in enhancing consumer engagement and improving advertiser performance. | META LIN AVGO ORCL GOOGL AAPL |
View |
| 2024 Q2 | Jun 30, 2024 | American Century International Growth Fund | 6.6% | 0.0% | 1299.HK, 4063.T, 6861.T, ADYEN.AS, AI.PA, AIR.PA, AKE.PA, ASML, AZN, CRH, EDEN.PA, IFX.DE, JHX, LSEG.L, MC.PA, NESN.SW, NVO, RELX.L, SAP, SRT3.DE, SU.PA, TM, TSM, UBS, UL | Asia, Energy Transition, Europe, healthcare, infrastructure, international, semiconductors, technology | The world's move away from fossil fuels creates opportunities across sectors. Increased demand for electric vehicles and large-scale renewable energy infrastructure projects creates inflection points for well-positioned businesses. AI investment is leading to significant increases in electricity demand to power data centers. | View | |
| 2024 Q1 | May 23, 2025 | RGA Investment Advisors | - | - | DHR, META, MRVI, MXCT, SRT3.DE | Biotechnology, Life Sciences, Portfolio Management, small caps, valuation | The fund significantly increased positions in life sciences companies including Maravai LifeSciences and Sartorius AG. Maravai offers critical mRNA capabilities through TriLink and quality control through Cygnus, with exceptional margins and growth potential as mRNA therapies advance to clinical trials. The biotech sector represents a key focus area with multiple investments across the value chain. | SRT3.DE MRVI META |
View |
| 2023 Q4 | May 23, 2024 | RGA Investment Advisors | 0.0% | 0.0% | META, MRVI, MXCT, SRT3.DE | Bioprocessing, Biotechnology, Life Sciences, mRNA, Portfolio Management, small caps, value | The fund significantly increased positions in life sciences companies including Maravai LifeSciences and initiated a position in Sartorius AG. Maravai offers critical mRNA manufacturing capabilities through TriLink and quality control testing through Cygnus, with exceptional margins and growth potential as mRNA therapies advance to clinical trials. The fund sees substantial opportunity in bioprocessing infrastructure as the industry scales. | SRT3.DE ADI|BDX|FI|FND|HAS|META|MSFT|MSI|ORCL|TMO |
View |
| 2025 Q1 | Apr 18, 2025 | Baillie Gifford -International All Cap | 0.5% | 0.5% | 2330.TW, 6273.T, 8035.T, ASML, BHP.AX, ROG.SW, SPX.L, SRT3.DE, UBS | banks, China, Cyclical, defense, Europe, growth, international, semiconductors | European defense companies have rallied strongly driven by government announcements of increased spending. However, determining which companies will benefit most remains challenging due to local politics, uncertainty about future warfare requirements, and significant re-rating that may have eliminated upside potential. | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Fund Letters | Concentrated Compounding | Sartorius AG | Health Care | Life Sciences Tools & Services | Bull | XETRA | Bioprocessing, contrarian, Cyclical Recovery, Germany, Laboratory Technologies, Life Sciences Tools, pharmaceuticals | View Pitch |
| Apr 28, 2026 | Fund Letters | RGA Investment Advisors | Sartorius AG | Health Care | Life Sciences Tools & Services | Bull | XETRA | Bioprocessing, Bioreactors, cell therapy, Europe, gene therapy, Life Sciences Tools, market share gains, Pure-Play, Single-Use, Value | View Pitch |
| Apr 13, 2026 | Fund Letters | RGA Investment Advisors | Sartorius AG | Health Care | Life Sciences Tools & Services | Bull | XETRA | Bioprocessing, cell therapy, European, gene therapy, Life Sciences Tools, market share gains, Pure-Play, Single-use Bioreactors | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||